Erste Asset Management Gmb H Novavax Inc Transaction History

Erste Asset Management Gmb H

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 22, 2024	SELL	$177.8 - $270.58 $3.13 Million - $4.76 Million	-17,600 Closed	0 $0
Q2 2021 Nov 22, 2024	SELL	$121.0 - $257.67 $1.44 Million - $3.07 Million	-11,900 Reduced 40.34%	17,600 $3.68 Billion
Q1 2021 Nov 22, 2024	BUY	$112.98 - $319.93 $3.33 Million - $9.44 Million	29,500 New	29,500 $5.11 Billion

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $722M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Erste Asset Management Gmb H with notifications on news.